Acetic acid 5-aziridin-1-yl-3,6-dimethyl-4,7-dioxo-4,7-dihydro-1H-indol-2-ylmethyl ester

ID: ALA119517

PubChem CID: 9943807

Max Phase: Preclinical

Molecular Formula: C15H16N2O4

Molecular Weight: 288.30

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)OCc1[nH]c2c(c1C)C(=O)C(N1CC1)=C(C)C2=O

Standard InChI:  InChI=1S/C15H16N2O4/c1-7-10(6-21-9(3)18)16-12-11(7)15(20)13(17-4-5-17)8(2)14(12)19/h16H,4-6H2,1-3H3

Standard InChI Key:  GTTCFXOKHIDTRD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    4.7167   -2.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7250   -2.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6792   -2.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6792   -2.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000   -2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2917   -3.0792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000   -3.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1625   -2.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2917   -2.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6500   -2.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8542   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5542   -2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1917   -1.4000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1917   -3.8000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2375   -2.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2167   -2.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6667   -2.8000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3542   -2.0250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1542   -3.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6417   -1.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6792   -3.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  5  1  0
  4  3  2  0
  5  1  1  0
  6  2  1  0
  7  2  1  0
  8  3  1  0
  9  1  1  0
 10  9  2  0
 11  8  1  0
 12  8  1  0
 13  5  2  0
 14  7  2  0
 15 17  1  0
 16 10  1  0
 17 16  1  0
 18 15  2  0
 19  4  1  0
 20  9  1  0
 21 15  1  0
  6 10  1  0
  4  7  1  0
 11 12  1  0
M  END

Associated Targets(Human)

Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colon carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cancer cell line (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prostatic carcinoma cell (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Breast carcinoma cell (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.30Molecular Weight (Monoisotopic): 288.1110AlogP: 1.35#Rotatable Bonds: 3
Polar Surface Area: 79.24Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.22CX Basic pKa: CX LogP: 0.49CX LogD: 0.49
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.67Np Likeness Score: 0.53

References

1. Skibo EB, Xing C, Dorr RT..  (2001)  Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles: structure-activity relationships for cytotoxicity and antitumor activity.,  44  (22): [PMID:11606119] [10.1021/jm010085u]
2. Xing C, Wu P, Skibo EB, Dorr RT..  (2000)  Design of cancer-specific antitumor agents based on aziridinylcyclopent[b]indoloquinones.,  43  (3): [PMID:10669573] [10.1021/jm990466w]

Source